Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy
2000
Molecular imaging in drug development
2008 Standout
Microbubbles in ultrasound-triggered drug and gene delivery
2008 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Validation of 68Ge/68Ga generator processing by chemical purification for routine clinical application of 68Ga-DOTATOC
2008
A Triazacyclononane‐Based Bifunctional Phosphinate Ligand for the Preparation of Multimeric 68Ga Tracers for Positron Emission Tomography
2010
In Vitro and In Vivo Evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor–Expressing Prostate Cancer
2011
68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression
2008
Preparation of high specific activity 86Y using a small biomedical cyclotron
2005
How is 68Ga Labeling of Macrocyclic Chelators Influenced by Metal Ion Contaminants in 68Ge/68Ga Generator Eluates?
2012
Be spoilt for choice with radiolabelled RGD peptides: Preclinical evaluation of 68Ga-TRAP(RGD)3
2012
Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐D Phe1,Tyr3‐octreotate) and 18F‐FDG
2008
68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
2007
A Monoreactive Bifunctional Triazacyclononane Phosphinate Chelator with High Selectivity for Gallium‐68
2012
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
Sequential Synthesis of Coordination Polymersomes
2014 StandoutNobel
Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines
2004
Radiometallated peptides for molecular imaging and targeted therapy
2011
A practical guide to the construction of radiometallated bioconjugates for positron emission tomography
2011
[68Ga]NS3-RGD and [68Ga] Oxo-DO3A-RGD for imaging αvβ3 integrin expression: synthesis, evaluation, and comparison
2012
Processing of Generator-Produced 68Ga for Medical Application
2007
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Radionuclide tumour therapy with ultrasound contrast microbubbles
2003
TRAP, a Powerful and Versatile Framework for Gallium‐68 Radiopharmaceuticals
2011
Infrared-based module for the synthesis of 68Ga-labeled radiotracers
2007
Somatostatin Analog Therapy in Treatment of Gastrointestinal Disorders and Tumors
2003
MicroPET Imaging of Breast Cancer Using Radiolabeled Bombesin Analogs Targeting the Gastrin-releasing Peptide Receptor
2006
68Ga‐PET: a powerful generator‐based alternative to cyclotron‐based PET radiopharmaceuticals
2008
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
2010
Gallium-68-labeled DOTA-rhenium-cyclized α-melanocyte-stimulating hormone analog for imaging of malignant melanoma
2007
A DOTA–peptide conjugate by copper-free click chemistry
2010
Bisphosphonate conjugation for bone specific drug targeting
2018
The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology
2011
Targeted delivery to bone and mineral deposits using bisphosphonate ligands
2015
Gallium(III) Complexes of DOTA and DOTA−Monoamide: Kinetic and Thermodynamic Studies
2010
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Molecular Imaging of Gastrin-Releasing Peptide Receptor-Positive Tumors in Mice Using64Cu- and86Y-DOTA−(Pro1,Tyr4)-Bombesin(1−14)
2007
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression
2005
microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
2004
H4octapa: An Acyclic Chelator for 111In Radiopharmaceuticals
2012
Combination therapy in combating cancer
2017 Standout
Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era
2010
Agonist−Antagonist Dilemma in Molecular Imaging: Evaluation of a Monomolecular Multimodal Imaging Agent for the Somatostatin Receptor
2007
Protein-Catalyzed Capture Agents
2019
Preparation and Biological Evaluation of Copper-64–Labeled Tyr3-Octreotate Using a Cross-Bridged Macrocyclic Chelator
2004
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications
2015
NIR-Activated Content Release from Plasmon Resonant Liposomes for Probing Single-Cell Responses
2012
Mono- and Bis-Alkylation of Glyoxal-Bridged Tetraazamacrocycles Using Mechanochemistry
2015
Tumor Imaging and Therapy Using Radiolabeled Somatostatin Analogues
2009
GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.
2005
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Mechanochemistry as an emerging tool for molecular synthesis: what can it offer?
2018 Standout
Works of Wouter A.P. Breeman being referenced
Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities
2003
Comparison of the binding and internalization properties of 12 DOTA-coupled and 111In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607
2011
Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver
1999
68Ga-labeled DOTA-Peptides and 68Ga-labeled Radiopharmaceuticals for Positron Emission Tomography: Current Status of Research, Clinical Applications, and Future Perspectives
2011
Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides
2010
Radiolabelling DOTA-peptides with 68Ga
2005
Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides
2008
Anti‐tumor effect and increased survival after treatment with [177Lu‐DOTA0,Tyr3]octreotate in a rat liver micrometastases model
2003
Simplified NaCl Based 68Ga Concentration and Labeling Procedure for Rapid Synthesis of 68Ga Radiopharmaceuticals in High Radiochemical Purity
2012
Scaled-up radiolabelling of DOTATATE with 68Ga eluted from a SnO2-based 68Ge/68Ga generator
2011
Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
2002
Lanthanide(III) Complexes of Bis(phosphonate) Monoamide Analogues of DOTA: Bone-Seeking Agents for Imaging and Therapy
2008